Drug Endangered Children Awareness ONLINE
This course examines the need and advantages of collaborative working arrangements at the local level between law enforcement, Division of Children and Family Services and other social service agencies when working cases that involve children living in homes where illegal drug activities occur. Participants will learn the history of the DEC movement nationally, the general history of drug use in the U.S., the effects and dangers of children living in homes where drugs are being used, manufactured or sold, drug recognition information and the advantages of local collaboration when dealing with DEC cases. Information about the Arkansas DEC Alliance will be shared and the Arkansas definition of drug endangered children will be explained.
This class can be taken as a stand-alone course or as a prerequisite for the intense DEC collaboration workshops that are offered around the State.
- Understand the significant events and history of the Drug Endangered Children’s Initiative at a national and state level.
- Discuss the development of U.S. national drug policies.
- Learn about the evolution of child protective services in the United States.
- Understand the risks to children due to illicit drug activities in their homes.
- Recognize the most common types of abused drugs and their paraphernalia.
- Discuss the power and effectiveness that comes from multi-disciplinary collaboration at the local level.
TARGET AUDIENCE: Law Enforcement and Division of Children and Family Services (DCFS) Professionals.
TRAINING HOURS: 7 hours
This class is available at no charge.
April 9-13, 2018
Registration ends 12pm (noon) April 6, 2018
May 7-11, 2018
Registration ends 12pm (noon) May 4, 2018
This project was supported by Grant # 2009CKWX0574 awarded by the U.S. Department of Justice, Office of Community Oriented Policing Services. The opinions contained herein are those of the author(s) and do not necessarily represent the official position or policies of the U.S. Department of Justice. References to specific companies, products, or services should not be considered an endorsement by the author(s) or the U.S. Department of Justice. Rather, the references are illustrations to supplement discussion of the issues.